Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma

Lung adenocarcinoma (LUAD) is the most prevalent subtype of non-small cell lung cancer (NSCLC) and is associated with high mortality rates. However, effective methods to guide clinical therapeutic strategies for LUAD are still lacking. The goals of this study were to analyze the relationship between...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yiming, Yang, Jun, Ji, Tiantai, Wen, Fengyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561349/
https://www.ncbi.nlm.nih.gov/pubmed/36246622
http://dx.doi.org/10.3389/fgene.2022.990623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561349/
https://www.ncbi.nlm.nih.gov/pubmed/36246622
http://dx.doi.org/10.3389/fgene.2022.990623

Ejemplares similares